50results about How to "Reduce load level" patented technology

The disclosure provides compositions prepared by combining nanomaterials with a halide-containing polymer, thereby forming a combined polymer matrix having dispersed nanomaterials within the matrix. The nanomaterials may be carbon-based nanotubes, in some applications. A halide-containing monomer is combined with nanotubes, and then polymerized in some compositions. In other applications, a halide-containing polymer is solution processed with nanotubes to form useful compositions in the invention. Also disclosed are probes for near field detection of radiation.

Rubber composition intended for the manufacture of tire casings which have improved hysteretic properties and scorch safety, based on at least one elastomer and silica by way of reinforcing filler enclosing a reinforcing additive consisting of the mixture and / or the product of in situ reaction of at least one functionalized polyorganosiloxane compound containing, per molecule, at least one functional siloxy unit capable of bonding chemically and / or physically to the surface hydroxyl sites of the silica particles and at least one functionalized organosilane compound containing, per molecule, at least one functional group capable of bonding chemically and / or physically to the polyorganosiloxane and / or the hydroxyl sites of the silica particles and at least one other functional group capable of bonding chemically and / or physically to the polymer chains.

An orthopedic joint replacement has first and second joint components that can be placed in load-bearing articulation with one another. The first joint component has first and second convex spherical condylar segments defining first and second radii. The second joint component has a spherical first concave condylar segment with a radius equal to the radius of the first convex spherical condylar segment. The second joint component also has a non-spherical second concave condylar segment. The first convex spherical condylar segment of the first joint component is in congruent contact with the first spherical concave condylar segment of the second joint component. The second spherical convex condylar segment of the first joint component is in line contact with the non-spherical concave condylar segment of the second joint component.

Disclosed are derivatives of isophorone diamine exhibiting a synergistic relationship with other commonly employed chain extenders offering enhanced efficacy with regard to slowing of the polyurea elastomer cure profile, and processes employing their use. According to the invention, extensions of the gel-free and tack-free times are more readily achieved at lower loading levels for these chain extender blends than are afforded through the sole use of the individual molecules.

A gas combustion treatment method for the combustion treatment of an ammonia-containing gas and a hydrogen sulfide-containing gas, the method comprising a first combustion treatment step in which the ammonia-containing gas, together with a fuel, is introduced and burned; a nitrogen oxide reduction step downstream of the first combustion treatment step, in which a portion of the hydrogen sulfide-containing gas or the ammonia-containing gas is introduced and the nitrogen oxides produced in the first combustion treatment step are reduced in a reducing atmosphere; and a second combustion treatment step downstream of the nitrogen oxide reduction step, in which the remaining hydrogen sulfide-containing gas, together with air, is introduced and burned. The present invention provides a combustion apparatus suitable for use as a combustion furnace for off-gases resulting from the wet purification of coal gasification gas.

Styrenic polymer foams, especially expanded and / or extruded styrenic polymer foams, are flame retarded by use of one or more flame retardant additives. These additives are i) a diether of tetrabromobisphenol-S, which ether groups do not contain bromine and wherein at least one of the ether groups is an allyl group; ii) a diether of tetrabromobisphenol-S, wherein at least one of the ether groups contains bromine; iii) a substituted benzene having a total of 6 substituents on the ring and wherein at least 3 of the substituents are bromine atoms and at least two of the substituents are C1-4 alkyl groups; iv) tribromoneopentyl alcohol; v) a tris(dibromoalkyl) benzenetricarboxylate in which each dibromoalkyl group contains, independently, 3 to 8 carbon atoms; vi) a brominated polybutadiene which is partially hydrogenated and / or aryl-terminated; vii) at least one brominated allyl ether of a novolac; viii) a brominated poly(1,3-cycloalkadiene); ix) a brominated poly(4-vinylphenol allyl ether); x) a brominated N,TSP-phenylenebismaleimide; xi) a brominated N,N′-(4,4′-methylenediphenyl)bismaleimide; xii) a brominated N,N′-ethylenebis-maleimide; xiii) ethylenebis(dibromonorbornane-dicarboxrmide); xiv) tetrabromobisphenol-A; or xv) a combination of any two or more of i) through xiv).

The present invention is directed to a microbial fuel cell comprising: A) an anode containing one or more conductive materials which is arranged to provide flow paths for electrons through the conductive material and to form flow paths for fluid material through passages formed in the conductive material, B) electrogenic microbes in electrical contact with the anode. C) biodegradable material disposed in a fluid, D) a cathode containing one or more conductive materials adapted such that the cathode can be contacted with an oxygen containing gas, E) an anion exchange membrane disposed between the anode and the cathode; and, F) a conduit for electrons which forms a circuit in contact with both the anode and the cathode.

A fast curable non-isocyanate-based polyurethane- and polyurethane-epoxy network nanocomposite polymeric compositions are derived upon crosslinking a mixture comprising of natural or modified nano-clay [ionic phyllosilicate] with platelet thickness in the scale of A (˜1 nm) and aspect ratio (length / thickness) higher than 10 (nm)] preferably natural or modified montmorillonite with either a monomer(s) or oligomer(s) bearing at least one cyclocarbonate group or a mixture of the latter with an epoxy resin, with a hardener, which is a monomer or oligomer or mixtures therefrom, bearing primary and / or secondary amino groups. The use of the nanoclays reduces the gel time and increases the adhesion of the cured polyurethane and polyurethane / epoxy hybrid and also reduces its water absorption.

A microbial fuel cell comprising an anode, a cathode, microbes in contact with the anode, a conduit for electrons connecting the anode to the cathode through an external circuit wherein the anode, cathode or both comprise a mixture of one or more conductive materials and one or more ion exchange materials.

Human scFvs are disclosed which interact with a conformational epitope along the pre-hairpin, N-helix coiled coil structure within the heptad repeat 1 (HR1) region of gp41 of HIV. These antibodies, as well as IgG conversions, are shown to neutralize diverse HIV isolates. Isolated nucleic acid molecules are also disclosed which encode relevant portions of these antibodies, as well as the purified forms of the expressed antibodies or relevant antibody fragments, such as VH and VL chains. The antibody compositions disclosed within this specification may provide for a therapeutic treatment against HIV infection by reducing viral load levels within an infected individual, thus prolonging the asymptomatic phase of HIV infection. These antibodies will also be useful in assays to identify HIV antiviral compounds as well as allowing for the identification of candidate HIV vaccines, such as HIV peptide vaccines.

Human scFvs are disclosed which interact with a conformational epitope along the pre-hairpin, N-helix coiled coil structure within the heptad repeat 1 (HR1) region of gp41 of HIV. These antibodies, as well as IgG conversions, are shown to neutralize diverse HIV isolates. Isolated nucleic acid molecules are also disclosed which encode relevant portions of these antibodies, as well as the purified forms of the expressed antibodies or relevant antibody fragments, such as VH and VL chains. The antibody compositions disclosed within this specification may provide for a therapeutic treatment against HIV infection by reducing viral load levels within an infected individual, thus prolonging the asymptomatic phase of HIV infection. These antibodies will also be useful in assays to identify HIV antiviral compounds as well as allowing for the identification of candidate HIV vaccines, such as HIV peptide vaccines.